Intravascular ultrasound and histopathological observations in a patient with very late sirolimus-eluting stent thrombosis  by Sonoda, Shinjo et al.
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s  u  m  m  a  r  y
This  case  report  describes  an autopsy  case  of very  late  stent  thrombosis,  which  was  associated  with
intravascular  ultrasound  ﬁndings  of  late-acquired  stent  malapposition  with  thrombotic  materials  and
marked  positive  vascular  remodeling  at the  site of  the  sirolimus-eluting  stent  implantation.  Histopatho-ccepted 23 April 2012
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logical  examination  showed  both  destructive  and  proliferative  reactions  had  occurred  in  the  same  stented
coronary  arterial  wall  44 months  after  sirolimus-eluting  stent  implantation.  Long-lasting  severe  local
inﬂammation  beyond  healing  reaction,  causing  vessel  enlargement,  may  be  related  to  very  late  stent
thrombosis.
©  2012  Japanese  College  of Cardiology.  Published  by  Elsevier  Ltd.  All rights  reserved.ntroduction
The mechanisms of very late stent thrombosis (VLST) after drug-
luting stent (DES) implantation are poorly understood. Recently, a
igh incidence of late stent malapposition (LSM) after DES implan-
ation has been indicated as the potential risk of VLST. We  report a
ase of VLST after sirolimus-eluting stent (SES) implantation, with
ntravascular ultrasound (IVUS) and histopathological investiga-
ions in autopsy specimens.
ase  report
A  72-year-old woman underwent a SES implantation (3.0 mm
n diameter; 18 mm in length) in the proximal left anterior descen-
ing artery (LAD) for effort angina (Fig. 1A and B). IVUS analysis
fter SES implantation showed adequate stent expansion with-
ut incomplete stent apposition (Fig. 1C). After 6 months of dual
ntiplatelet therapy (DAPT) (aspirin 100 mg  and ticlopidine 200 mg
 DOI  of commentary article: http://dx.doi.org/10.1016/j.jccase.2012.08.005.
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878-5409/$ – see front matter © 2012 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jccase.2012.04.007daily), she continued taking aspirin (100 mg/day) without follow-
up angiography. She had no history of allergic disease. Forty-four
months later, she suffered from a sudden continuous chest pain
and was admitted to our hospital. Electrocardiogram showed ST-
segment elevation in the precordial leads. Emergent coronary
angiography revealed total occlusion in the proximal LAD (Fig. 1D).
Subsequently, intracoronary aspiration thrombectomy and high-
pressure balloon dilatation using a noncompliant balloon catheter
(3.0 mm in diameter) were performed for the treatment of throm-
botic LAD lesion. After procedure, thrombolysis in myocardial
infarction grade-2 ﬂow was achieved without signiﬁcant stenosis
in the stented lesion (Fig. 1E). IVUS showed LSM with thrombotic
materials and marked positive vascular remodeling in the mid por-
tion of the SES (Fig. 1F). External elastic membrane (EEM) had
enlarged from 12.5 mm2 just after stenting to 24.2 mm2 at the
time of VLST. Positive vascular remodeling existed on the disease
side of the vessel wall. Despite re-opening of the culprit coro-
nary artery, she died because of post infarction myocardial rupture
immediately after percutaneous coronary intervention. Autopsy
was performed after obtaining written informed consent from the
patient’s family. The heart was ﬁxed in 10% buffered formalin.
Epicardial coronary arteries were dissected off the heart and radio-
graphed. The metal stent wires were removed by careful pulling
under a dissecting microscope with a pair of watchmaker’s forceps.
Each 2-mm coronary slab was  routinely processed and embed-
vier Ltd. All rights reserved.
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Figure 1. Angiographic and IVUS ﬁndings at baseline (A–C) and 44 months after SES implantation (D–F); (A) 90% stenosis of proximal LAD before PCI (arrow). (B) LAD
after SES (3.5 mm in diameter; 18 mm in length) implantation (arrow). (C) IVUS image post SES implantation demonstrating adequate stent expansion with no evidence
of incomplete stent apposition. (D) Very late stent thrombosis occurred at the proximal portion of the SES. (E) TIMI grade 2 ﬂow was obtained without signiﬁcant stenosis
in  the LAD. (F) IVUS image after intracoronary aspiration thrombectomy and high-pressure balloon dilatation. LSM with thrombotic material and marked positive vascular
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Eemodeling in the mid  portion of SES. EEM (dotted line) had enlarged from 12.5 mm
eft  anterior descending coronary artery; PCI, percutaneous coronary intervention; 
alapposition; and EEM, external elastic membrane.
ed in parafﬁn. In addition, the stented segment with positive
emodeling was submitted for plastic embedding for further exam-
nation. All sections underwent hematoxylin and eosin staining and
everal immunohistochemical stainings. The autopsy revealed
igure 2. Histopathology of cross-sections of slightly distal portion of the SES-implante
emodeling. The space between stent struts and vessel wall is ﬁlled with blood compone
tent struts. (C–E) High-magnitude microscopic images of (B). (C) Severe inﬂammatory
osinophils (D) and plasma cells (E) were present around the struts. SES, sirolimus-elutinafter stenting to 24.2 mm2 at the time of VLST. IVUS, intravascular ultrasound; LAD,
rolimus-eluting stent; TIMI, thrombolysis in myocardial infarction; LSM, late stent
fresh  ﬁbrin deposition existed behind the malapposed stent
struts in the segment with positive remodeling (Fig. 2A). Arte-
rial walls showed extremely severe localized inﬁltration (Fig. 2B).
High-magnitude microscopic images showed predominantly mul-
d coronary artery segment. (A) Note focal stent strut malapposition with positive
nts, which consist mainly of ﬁbrin (arrowheads). (B) Severe inﬂammation around
 inﬁltration consisting predominantly of multinucleated giant cells, lymphocytes.
g stent. (A–E) Hematoxylin and eosin stain. Arrowheads: ﬁbrin thrombus.
e128 S. Sonoda et al. / Journal of Cardiology Cases 6 (2012) e126–e129
Figure 3. Histopathology of cross-sections of slightly distal portion of the SES-implanted coronary artery segment. B-lymphocytes (A) and IgG-positive plasma cells (B) were
present  around the struts. SES, sirolimus-eluting stent. (A) L26 stain and (B) IgG stain.
Figure 4. Inﬂammation and proliferation of smooth muscle cells around apposed stent struts. (A) Low magniﬁcation image of whole vessel. (B) High resolution image around
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atruts.  Smooth muscle cells proliferation (brown) occurred around apposed struts.
truts. (A and B) SMC  -actin stain; (C) CD68 stain. SMC, smooth muscle cell; CD, c
gure legend, the reader is referred to the web version of the article.)
inucleated giant cells and lymphocytes (Fig. 2C). Eosinophils
Fig. 2D) and plasma cells (Fig. 2E) also existed around the struts.
mmunohistochemical stainings showed B-lymphocytes (Fig. 3A:
26 stain) and IgG-positive plasma cells (Fig. 3B: IgG stain) were
resent around the struts, respectively. In addition, inﬂammation
nd proliferation of smooth muscle cells existed around apposed
tent struts. Smooth muscle cell (SMC) -actin stain reveled that
mooth muscle cell proliferation (brown) occurred around apposed
truts (Fig. 4A and B). Furthermore, cluster of differentiation (CD)
8 stain showed macrophage inﬁltration (brown) also occurred
round the struts adjacent to apposed struts (Fig. 4C). Both inﬂam-acrophages inﬁltration (brown) also occurred around the struts adjacent apposed
 of differentiation. *Stent strut. (For interpretation of the references to color in this
matory  destructive and inﬂammatory proliferative reactions were
coexistent in the lesion of stent thrombosis.
Discussion
VLST is a serious problem in the DES era. Although stent throm-
bosis is a multifactorial problem that is dependent on patients,
lesions, devices, and procedural factors, the status of DAPT is
essential to consider. Discontinuation of DAPT at less than 1 year
after DES implantation is one of the most signiﬁcant independent
predictors of stent thrombosis [1]. However, no apparent clinical
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eneﬁt was received from thienopyridine use beyond 6–12 months
fter SES implantation [2,3]. Because there were no strong risk fac-
ors for stent thrombosis at the time of SES implantation in this
ase, only aspirin was maintained beyond 6 months. Long intervals
etween discontinuation of thienopyridine and stent thrombosis
ast doubt on the relationship between theinopyridine cessation
nd VLST.
Recently, a high incidence of LSM after DES implantation has
een indicated as a potential risk for VLST. Cook et al. evaluated 10
atients with VLST by both IVUS and histopathological examina-
ion of aspirated thrombi, demonstrating that VLST was  associated
ith LSM accompanying positive vessel remodeling and vascular
nﬂammation [4]. Virmani et al. demonstrated localized hypersen-
itivity vasculitis in a patient who eventually died of VLST after SES
mplantation [5]. Malapposed stent struts and thick ﬁbrin thrombus
xisted between the stent struts and arterial wall. Accumulation
f T-lymphocytes and eosinophils is associated with aneurysmal
ilatation of the vessel wall. The current case demonstrated severe
nﬂammation inﬁltrated into whole vascular wall consisting of mul-
inucleated giant cells, lymphocytes, plasma cells, macrophages,
nd some eosinophils in conjunction with vessel enlargement.
specially, B-lymphocytes and IgG-positive plasma cells indicate
xtremely severe inﬂammation. There was fresh ﬁbrin formation
etween malapposed stent struts and arterial wall. In this case,
owever, inﬂammatory proliferative response also existed around
djacent apposed stent struts. Both inﬂammatory destructive and
nﬂammatory proliferative reactions were coexistent in the stented
oronary arterial wall 44 months after DES implantation. Accumu-
ating evidence suggests that VLST associated with LSM, peri-stent
ontrast staining (PSS), and coronary aneurysm might be mechanis-
ically related to chronic inﬂammatory reactions [6,7]. Long-lasting
evere inﬂammation might lead to coronary aneurysm formation
rom LSM and/or PSS. Furthermore, the incidences of early and
ate restenosis tended to be higher in lesions with PSS than in
esions without PSS. Sustained inﬂammation might be operative
or both VLST and restenosis after DES implantation. Hao et al.
eported the coexistence of inﬂammatory reaction, persistent ﬁbrin
eposition, and neointimal hyperplasia in restenotic lesion after
ES implantation [8]. These interesting ﬁndings suggested that
ustained inﬂammation of coronary arterial wall could be concur-
ent with restenotic reaction after DES implantation. Alfonso et al.
eported that both coronary aneurysm and in-stent restenosis con-
omitantly developed in the DES implanted segments [9]. Patients
ndergoing DES implantation who have elevated inﬂammatory
iomarkers (such as high sensitive C-reactive protein) may  be at
[gy Cases 6 (2012) e126–e129 e129
increased risk for future DES restenosis and thrombosis [10]. In the
current case, however, there were no elevated eosinophils on the
peripheral smear, serum IgE, and high sensitive C-reactive protein,
which suggested hypersensitivity vasculitis. To discriminate PSS
and/or coronary aneurysm, follow-up coronary angiography might
be useful. Because optimal management is currently unknown,
DAPT should be continued beyond 1 year in such patients. To pre-
vent such tragic DES-related complications, further studies are
required to search precise mechanisms of VLST.
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